PRF Technologies Stock (NASDAQ:PRFX)
Previous Close
$3.46
52W Range
$2.57 - $17.95
50D Avg
$3.90
200D Avg
$6.41
Market Cap
$239.99K
Avg Vol (3M)
$538.26K
Beta
0.54
Div Yield
-
PRFX Company Profile
PRF Technologies Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.